- Papua New Guinea (PNG) has a low-level mixed HIV epidemic and the highest HIV incidence and prevalence in the Pacific region.
- Tuberculosis (TB) remains a major public health threat in PNG with a high incidence rate (432 per 100,000) and a rapid rise of multi-drug resistant/rifampicin resistant TB (MDR-RR-TB).
- The grant will support priorities and interventions in alignment with the National STI and HIV Strategy 2018-2022 and the National Tuberculosis Strategic Plan 2015-2020.
Principles of implementation are:
- Task shifting/ sharing (involving community)
- Provincial implementation in line with the existing decentralised model - national health plan
- Policy guidance and technical support through national level
The main project objectives are to:
- Increase the TB case notification rate for bacteriologically - confirmed, new and relapse cases, from 43 per 100,000 population in 2013 to 93 per 100,000 population in 2020
- Increase the TB treatment success rate of bacteriologically – confirmed new TB cases from 68 percent in 2012 to 88% in 2020;
- Increase the coverage of HIV testing of TB patients from <25 percent in 2013 to >90 percent in 2020
- 70% of PLHIV know their status by 2020;
- 70% of PLHIV are accessing antiretroviral therapy by 2020;
- 90% of PLHIV on ART have a suppressed viral load within 12 months of commencing ART by 2020; and
- Contribute in ensuring uninterrupted supply of drugs and medical products for Malaria, TB and HIV programs through effective operationalisation of m-Supply, a Logistics Management Information System (LMIS), among existing and expansion sites in 2017 and 2020 respectively.
- Initiate pilot TBHIV programs within local communities to reduce the burden of TBHIV transmission
- Promote and strengthen TBHIV infrastructure with respective Provincial Health Authorities, stakeholders and NGO’s
Burnet Institute is the Sub-Recipient to World Vision on this grant and implements in 3 provinces namely;
- East New Britain
- New Ireland
- West New Britain
Jan 2018 – end 2022